MPT-0118

N/A

Report date: 2024/11/25 20:00:28
NME

Base Information

Drug NameMPT-0118
Drug Alias NameMPT-0118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitors
TargetsMucosa-associated lymphoid tissue lymphoma translocation protein 1
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMonopteros Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMonopteros Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasm MetastasisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A